"Could AstraZeneca/Resverlogix run with it regardless, should the duet ABL+ Crestor(Rosuvastatin) is a success in the BOM trial, especially with Resverlogix holding a patent claims covering the use of apabetalone in combination with Rosuvastatin?"

Do you mean run a follow up cardiovascular outcomes trial in the event that BETonMACE does not support NDA or MAA approval?

BDAZ